Alexis Brice – Director, Brain & Spine Institute (ICM), France
Prof. Alexis Brice, director of the French Brain & Spine Institute (Institut du Cerveau et de la Moelle épinière (ICM)), reveals the recipe behind the success of the center since…
Vifor Pharma is a world leader in the discovery, development, manufacturing and marketing of pharmaceutical products for the treatment of iron deficiency. As a fully integrated specialty pharmaceutical company and a recognized worldwide leader in the treatment of iron deficiency, Vifor Pharma has an increasingly global presence with broad market coverage in Europe as well as with regional offices in North and South America and Asia. Vifor Pharma is present in more than 100 countries. The French affiliate acts as the marketing authorization holder and regulatory office for all European affiliates. With 70 employees and more than 40 million euros (USD 43.08 million) in turnover, the French affiliate has ambitious objectives.
Contact
c/o OM Pharma SA
Rue du Bois-du-Lan 22, case postale
CH-1217 Meyrin 2
Tel: +41 22 783 11 11
Fax: +41 22 783 11 22
Web: viforpharma.com/fr
Prof. Alexis Brice, director of the French Brain & Spine Institute (Institut du Cerveau et de la Moelle épinière (ICM)), reveals the recipe behind the success of the center since…
Emmanuel Eumont, general manager of Gedeon Richter France, discusses the group’s leading position in women’s health, its external growth strategy, notably through the acquisition of Finox Biotech in 2016, and…
Dominique Martin, CEO of the ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé) provides a fascinating insight into the French process of authorizing drugs and medical…
Dr. Denis Comet, President of AFCRO (the French Association of CROs), talks about the evolution of the clinical research environment in France and the new government actions aimed at speeding…
Didier Geneau provides a fascinating insight into the French biotech scene; its strengths but also weaknesses. France has an incredible track-record of excellence in innovation and, for the first time…
Photo Copyright: Olivier Corsan Alain-Michel Ceretti, president of France Assos Santé (the French Union of the Registered Associations for the Users of the Health System), tells us about his…
Prof. Stanislas Lyonnet, director of the Imagine Institute in Paris, France, explains his organization’s unique ecosystem that brings together researchers, physicians, patients and private actors to find the cure to…
France is attempting to reposition itself as a globally competitive hub for artificial intelligence R&D, with significant state investment aiming to turn Paris into the next Palo Alto. With rapid…
Professor José-Alain Sahel, founder and director of the Institute de la Vision in Paris, offers his insider take on the ophthalmology landscape in France, international perceptions of the country, and…
Bertrand Letartre of Anios discusses the company’s rich history, their move towards more technical offerings with the acquisition of Soluscope, internationalization, family values, and the company’s mission to spread awareness…
In an exclusive interview, Agnès Buzyn, Chairwoman of the Board for the French National Authority for Health (Haute Autorité de Santé – HAS), on her organization’s priorities, the particularities of…
Shedding light on the unique business model of French pharma’s most successful mid-cap. Not long ago, Laboratories Servier was considered a somewhat mysterious and opaque actor on the world…
See our Cookie Privacy Policy Here
